Anthem Inc (ANTM) Given Average Recommendation of “Buy” by Analysts
Anthem Inc (NYSE:ANTM) has been given an average rating of “Buy” by the twenty analysts that are currently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and seventeen have given a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $269.77.
ANTM has been the subject of a number of recent analyst reports. Citigroup cut Anthem from a “buy” rating to a “neutral” rating and set a $162.00 price objective for the company. in a research report on Monday. Morgan Stanley raised Anthem from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $273.00 to $368.00 in a research report on Wednesday, September 5th. Credit Suisse Group raised their price objective on Anthem from $284.00 to $311.00 and gave the company an “outperform” rating in a research report on Tuesday, September 4th. Zacks Investment Research cut Anthem from a “buy” rating to a “hold” rating in a research report on Tuesday, July 3rd. Finally, ValuEngine cut Anthem from a “buy” rating to a “hold” rating in a research report on Friday, June 1st.
In other Anthem news, EVP Craig E. Samitt sold 19,541 shares of the firm’s stock in a transaction on Thursday, July 26th. The stock was sold at an average price of $246.68, for a total transaction of $4,820,373.88. Following the transaction, the executive vice president now owns 20,857 shares in the company, valued at approximately $5,145,004.76. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Peter D. Haytaian sold 3,500 shares of the firm’s stock in a transaction on Monday, August 27th. The stock was sold at an average price of $265.92, for a total value of $930,720.00. Following the transaction, the executive vice president now owns 57,674 shares in the company, valued at approximately $15,336,670.08. The disclosure for this sale can be found here. In the last quarter, insiders have sold 26,988 shares of company stock worth $6,812,655. 0.31% of the stock is owned by corporate insiders.
Shares of ANTM traded up $4.44 during mid-day trading on Friday, reaching $270.78. The company’s stock had a trading volume of 56,829 shares, compared to its average volume of 1,036,136. Anthem has a 1-year low of $179.40 and a 1-year high of $273.14. The stock has a market cap of $68.67 billion, a price-to-earnings ratio of 22.45, a PEG ratio of 1.44 and a beta of 0.90. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 0.61.
Anthem (NYSE:ANTM) last released its quarterly earnings data on Wednesday, July 25th. The company reported $4.25 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $4.16 by $0.09. Anthem had a return on equity of 13.28% and a net margin of 4.79%. The company had revenue of $22.71 billion during the quarter, compared to analysts’ expectations of $22.66 billion. During the same period last year, the firm posted $3.37 earnings per share. The business’s revenue was up 2.3% on a year-over-year basis. analysts expect that Anthem will post 15.48 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 25th. Stockholders of record on Monday, September 10th will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Friday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.11%. Anthem’s dividend payout ratio (DPR) is currently 24.92%.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Further Reading: What do I need to know about analyst ratings?
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.